$ASAN

UBS reiterates Asana stock rating at neutral on AI adoption pace

UBS reiterated a Neutral rating on Asana (NYSE:ASAN) with a $10.00 price target, noting early AI adoption and positive product strategy evolution. Asana's stock trades at $10.12 with a $2.32B market cap, showing 9.48% revenue growth and 87.59% gross margin. Recent Q2 results beat expectations with $0.10 EPS and $216.4M revenue, up 10% YoY. Analysts have mixed outlooks on future growth.

Original reporting
Published Oct 16, 2026, 2:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 2:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ASAN
Neutral
medium confidence
Mentioned
$ASAN
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ASANNeutralMed
01

Why it matters

The rating and target adjustment provide a fresh catalyst for Asana, though the neutral stance tempers immediate trade enthusiasm.

02

Market read

Analyst rating updates and recent earnings beat provide modest trading relevance for Asana (ASAN).

03

What to watch

Potential upside from upcoming AI‑driven product releases and long‑term contract renewals not fully reflected in current guidance.

Relevance 6/10Novelty 6/10Timing: post-market today

Background

UBS analysts attended Asana's conference, reviewed new product offerings, and updated their valuation model based on recent earnings.

Company-level read

Ticker impact

$ASANNeutralMedium confidence
Context

UBS reiterated a Neutral rating on Asana with a $10 price target and discussed recent Q2 fiscal 2027 earnings beat and revenue growth.

Expected impact

likely slight upward pressure as investors weigh the new target against mixed guidance outlook

Evidence & confidence

The rating change provides a fresh data point, but the neutral stance and mixed guidance limit the trade conviction.

Market effects

Highlights ongoing AI adoption challenges for SaaS productivity tools, affecting peers in the enterprise software space.

U.S. market focus; limited broader regional effect.

Modest, as Asana is a small-cap player in the global AI‑enabled software sector.

Counterpoint

The neutral rating may undervalue Asana's high gross margins and expanding product suite, suggesting upside if AI adoption accelerates.

Key entities

  • UBS

    Reiterated Neutral rating and raised price target to $10.

  • DA Davidson

    Raised price target to $9.

  • Citizens

    Maintains Market Outperform rating with $15 target.

Related articles

$ASANMed

D.A. Davidson reiterates Neutral on Asana stock, $9 target

D.A. Davidson reiterated a Neutral rating and $9 price target for Asana (ASAN), citing growth potential from multi-product expansion and AI acquisition. ASAN stock is up 35% in six months, with Q2 revenue beating estimates at $216.4M. Analysts highlight strong gross margins and profitability expectations. UBS and Citizens also raised price targets, citing improved metrics and strategic adjustments.

$ASANMed

Asana (ASAN) Q2 2027 Earnings Call Transcript

Asana (ASAN) reported Q2 2027 revenue of $216.4M, up 10% YoY, exceeding guidance. Non-GAAP operating margin was 10.1%, up 300 bps YoY. Net retention rates improved across all cohorts, with AI products driving 25% of net new ARR. The company faces PLG headwinds and gross margin pressure due to AI investments. Q3 revenue guidance is $217M-$219M, with full-year revenue expected at $858.5M-$863.5M, up 9% at the midpoint.

$NVDAHighAI 8/10

Consumer Tech (Aug 31-Sep 4): NVIDIA Buys World's Largest Open AI Developer, Trump Claims Total Control On Hormuz & More

NVIDIA (NVDA) agreed to acquire Hugging Face for $12.93B. Ambarella (AMBA), Asana (ASAN), Samsara (IOT), and others reported earnings beats. Dell (DELL) and Salesforce (CRM) saw strong AI-driven demand. NIO (NIO) missed revenue estimates. TSMC (TSM) raised chip equipment spending. Meta (META) opposed AI regulation. Broadcom (AVGO) and Microsoft (MSFT) expanded AI chip and reporting initiatives.

$ASANMedAI 8/10

Asana, Inc. Q2 2027 Earnings Call Summary

Asana (ASAN) reported Q2 2027 revenue beat, driven by U.S. growth and AI products contributing 25% of net new ARR. Management raised AI product target to 20% of net new ARR for the year. Gross margins expected to exit in mid-80s due to AI costs. Guidance includes a $1.2M revenue timing headwind from consumption-based billing. New applications expected to contribute meaningfully in 2028.

$ASANHighAI 8/10

Asana Shares Fall 10.9% as Q3 Outlook Follows Q2 Earnings Beat

Asana (ASAN) shares dropped 10.9% in pre-market trading after reporting Q2 revenue of $216.4M, up 10% YoY, and adjusted EPS of $0.10, beating estimates. Q3 guidance was below expectations, with revenue forecasted at $217M-$219M and adjusted EPS at $0.08. Gross margin declined to 87% due to AI costs and integration expenses. Analysts maintained ratings but adjusted price targets.

$ASANMedAI 8/10

Asana (ASAN) Reached a 10% Non-GAAP Operating Margin. Can Agentic Products Restore Expansion?

Asana (ASAN) reported Q2 2027 revenue of $216.4M, up 10% YoY, with a 10.1% non-GAAP operating margin. Core revenue grew 11%, and cash flow improved. Agentic Work Management, launching Q3, may introduce new revenue streams. Retention remains a concern at 97%. GAAP vs. non-GAAP margin gap is significant. Fiscal 2027 guidance expects ~9% revenue growth and ~10% non-GAAP margin.